Singhaviranon, Summit
Dempsey, Joseph P.
Hagymasi, Adam T. https://orcid.org/0000-0002-2805-8349
Mandoiu, Ion I.
Srivastava, Pramod K. https://orcid.org/0000-0003-2837-2861
Funding for this research was provided by:
Neag Cancer Immunology Translational Program Northeastern Utilities Chair in Experimental Oncology
National Science Foundation (2212511)
Article History
Received: 26 March 2024
Accepted: 25 November 2024
First Online: 9 January 2025
Competing interests
: P.K.S. is a founder of Agenus and a founder, board member and stock owner of Life Science Pharmaceuticals. The other authors declare no competing interests.